What is Monroe Capital's earnings per share (EPS)?

Monroe Capital (MRCC) reported diluted earnings per share of $-0.24 for fiscal year 2025. This represents a -153.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Monroe Capital Financials

MRCC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Monroe Capital (MRCC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI MRCC FY2025 2026-04-29

FY2025 cash generation mostly reflects balance-sheet shrinkage, with deleveraging replacing earnings growth as the main mechanic.

In FY2025, operating cash flow of $115.9M arrived alongside a net loss of -$5.1M, so cash generation and accounting earnings diverged sharply. Because total assets also dropped to $373.0M from $490.7M, the cleaner reading is asset conversion and deleveraging rather than a step-up in underlying earning power.

The balance sheet has been shrinking for several years: assets moved from $590.5M in FY2021 to $373.0M in FY2025. Liabilities fell even faster, which pushed debt to equity down to 1.1x in FY2025 from 1.5x in FY2024, but that improvement came through contraction, not growth.

The payout record looks heavier than earnings capacity: the dividend stayed at $1.00 per share through FY2024 even though profits were negative or near zero in FY2022 and FY2023. That helps explain why retained earnings slid from -$49.2M to -$131.1M, meaning book value has been used as part of the support for shareholder distributions.

Financial Health Signals

Financial Profile 15/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Monroe Capital's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Leverage

Monroe Capital carries a low D/E ratio of 1.15, meaning only $1.15 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 79/100, indicating a strong balance sheet with room for future borrowing.

Returns

Monroe Capital generates a -3.1% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 11/100. This is down from 5.1% the prior year.

Piotroski F-Score Neutral

4/9

Monroe Capital passes 4 of 9 financial strength tests. 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass.

Earnings Quality Mixed

-22.62x

For every $1 of reported earnings, Monroe Capital generates $-22.62 in operating cash flow ($115.9M OCF vs -$5.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$5.1M

YoY-152.8%

Monroe Capital reported -$5.1M in net income in fiscal year 2025. This represents a decrease of 152.8% from the prior year.

EPS (Diluted)

$-0.24

YoY-153.3%

Monroe Capital earned $-0.24 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 153.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$1.9M

YoY-78.7%

5Y CAGR-22.2%

Monroe Capital held $1.9M in cash against $190.8M in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.93

YoY-7.0%

5Y CAGR-3.3%

Monroe Capital paid $0.93 per share in dividends in fiscal year 2025. This represents a decrease of 7.0% from the prior year.

Shares Outstanding

22M

YoY+0.0%

Monroe Capital had 22M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-3.1%

YoY-8.1pp

5Y CAGR-3.8pp

Monroe Capital's ROE was -3.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 8.1 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

MRCC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$800K-17.0%	$964K-17.9%	$1.2M+8.5%	$1.1M+0.9%	$1.1M+8.4%	$989K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$15.9M-27.6%	$21.9M-4.1%	$22.8M+33.8%	$17.1M+6.3%	$16.1M-10.6%	$18.0M
Income Tax	$141K+3625.0%	-$4K-101.2%	$321K-75.5%	$1.3M+32675.0%	$4K+100.0%	$2K
Net Income	-$5.1M-152.8%	$9.7M+2515.6%	$371K+113.3%	-$2.8M-108.6%	$32.5M+1872.0%	$1.6M
EPS (Diluted)	$-0.24-153.3%	$0.45+2150.0%	$0.02+115.4%	$-0.13-108.6%	$1.51+1787.5%	$0.08

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	$152K-34.5%	$232K+2.7%	$226K	N/A	$270K+11.1%	$243K+11.5%	$218K
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	N/A	$3.9M-0.5%	$3.9M-15.9%	$4.7M	N/A	$5.5M-4.6%	$5.8M+5.0%	$5.5M
Income Tax	N/A	$114K+1800.0%	$6K+500.0%	$1K	N/A	$0+100.0%	-$20K-385.7%	$7K
Net Income	N/A	-$1.1M+39.2%	-$1.9M-451.3%	$532K	N/A	$5.0M+52.4%	$3.3M+2.0%	$3.2M
EPS (Diluted)	N/A	$-0.05+44.4%	$-0.09-400.0%	$0.03	N/A	$0.23+53.3%	$0.150.0%	$0.15

MRCC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$373.0M-24.0%	$490.7M-4.4%	$513.2M-9.2%	$565.0M-4.3%	$590.5M	N/A
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.9M-78.7%	$9.0M+82.4%	$5.0M-9.0%	$5.5M+107.9%	$2.6M-61.3%	$6.8M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$206.5M-30.9%	$298.9M-3.4%	$309.5M-9.0%	$340.0M-0.3%	$341.0M	N/A
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$190.8M-34.7%	$292.0M-3.0%	$300.9M-8.9%	$330.1M-0.6%	$332.2M	N/A
Total Equity	$166.5M-13.2%	$191.8M-5.9%	$203.7M-9.5%	$225.0M-9.8%	$249.5M+6.4%	$234.4M
Retained Earnings	-$131.1M-23.7%	-$106.0M-12.2%	-$94.4M-28.1%	-$73.7M-49.7%	-$49.2M	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$373.0M-4.1%	$389.0M-1.4%	$394.6M-14.5%	$461.5M-5.9%	$490.7M-2.2%	$501.9M-2.0%	$512.1M-2.9%	$527.5M
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash & Equivalents	$1.9M-45.4%	$3.5M+45.4%	$2.4M-62.5%	$6.5M-28.5%	$9.0M+122.2%	$4.1M+5.0%	$3.9M-20.2%	$4.9M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$206.5M-4.4%	$215.9M+0.4%	$215.0M-21.7%	$274.6M-8.1%	$298.9M-1.3%	$303.0M-3.1%	$312.8M-4.1%	$326.0M
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Long-Term Debt	$190.8M-9.7%	$211.2M+1.3%	$208.6M-22.5%	$269.1M-7.8%	$292.0M-1.6%	$296.7M-2.8%	$305.2M-4.3%	$318.8M
Total Equity	$166.5M-3.8%	$173.0M-3.6%	$179.6M-3.9%	$186.9M-2.5%	$191.8M-3.6%	$198.9M-0.2%	$199.3M-1.1%	$201.5M
Retained Earnings	-$131.1M-5.2%	-$124.7M-5.5%	-$118.1M-6.6%	-$110.9M-4.6%	-$106.0M-6.8%	-$99.3M-0.5%	-$98.8M-2.2%	-$96.6M

MRCC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$115.9M+222.2%	$36.0M-30.5%	$51.7M+266.7%	$14.1M-29.5%	$20.0M-73.3%	$74.9M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$123.0M-285.9%	-$31.9M+39.0%	-$52.2M-95.4%	-$26.7M+22.1%	-$34.3M+52.5%	-$72.1M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$23.2M+438.5%	$4.3M-93.1%	$62.3M+139.0%	$26.1M+68.3%	$15.5M+7.5%	$14.4M-21.4%	$18.3M+249.3%	-$12.3M
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$24.8M-673.2%	-$3.2M+95.2%	-$66.3M-131.5%	-$28.6M-172.4%	-$10.5M+26.0%	-$14.2M+26.4%	-$19.3M-258.5%	$12.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

MRCC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	-3.1%-8.1pp	5.1%+4.9pp	0.2%+1.4pp	-1.2%-14.2pp	13.0%+12.3pp	0.7%
Return on Assets	-1.4%-3.4pp	2.0%+1.9pp	0.1%+0.6pp	-0.5%-6.0pp	5.5%	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.15-0.4	1.52+0.0	1.480.0	1.47+0.1	1.33	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	-0.7%+0.4pp	-1.0%-1.3pp	0.3%	N/A	2.5%+0.9pp	1.6%+0.0pp	1.6%
Return on Assets	N/A	-0.3%+0.2pp	-0.5%-0.6pp	0.1%	N/A	1.0%+0.4pp	0.6%+0.0pp	0.6%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Debt-to-Equity	1.15-0.1	1.22+0.1	1.16-0.3	1.44-0.1	1.52+0.0	1.49-0.0	1.53-0.1	1.58
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Similar Companies

Tortoise Sustainable and Social Impact TEAF

$164.7M

Portman Ridge Fin Corp PTMN

$161.8M

Whitehorse WHF

$142.9M

Blackstone Senior Floating Rate 2027 Term Fund BSL

$169.9M

Oxford Square Ca OXSQ

$129.1M

Frequently Asked Questions

Is Monroe Capital profitable?

No, Monroe Capital (MRCC) reported a net income of -$5.1M in fiscal year 2025.

How much debt does Monroe Capital have?

As of fiscal year 2025, Monroe Capital (MRCC) had $1.9M in cash and equivalents against $190.8M in long-term debt.

Does Monroe Capital pay dividends?

Yes, Monroe Capital (MRCC) paid $0.93 per share in dividends during fiscal year 2025.

What is Monroe Capital's return on equity (ROE)?

Monroe Capital (MRCC) has a return on equity of -3.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Monroe Capital's operating cash flow?

Monroe Capital (MRCC) generated $115.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Monroe Capital's total assets?

Monroe Capital (MRCC) had $373.0M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Monroe Capital have outstanding?

Monroe Capital (MRCC) had 22M shares outstanding as of fiscal year 2025.

What is Monroe Capital's debt-to-equity ratio?

Monroe Capital (MRCC) had a debt-to-equity ratio of 1.15 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Monroe Capital's return on assets (ROA)?

Monroe Capital (MRCC) had a return on assets of -1.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Monroe Capital's Piotroski F-Score?

Monroe Capital (MRCC) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Monroe Capital's earnings high quality?

Monroe Capital (MRCC) has an earnings quality ratio of -22.62x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Monroe Capital?

Monroe Capital (MRCC) scores 15 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.